EMITF
Price
$2.00
Change
-$0.00 (-0.00%)
Updated
Mar 18 closing price
Capitalization
11.9M
IQV
Price
$154.73
Change
-$12.96 (-7.73%)
Updated
Apr 4 closing price
Capitalization
45.3B
24 days until earnings call
Ad is loading...

EMITF vs IQV

Header iconEMITF vs IQV Comparison
Open Charts EMITF vs IQVBanner chart's image
Elbit Imaging
Price$2.00
Change-$0.00 (-0.00%)
Volume$167
Capitalization11.9M
IQVIA Holdings
Price$154.73
Change-$12.96 (-7.73%)
Volume$2.56M
Capitalization45.3B
EMITF vs IQV Comparison Chart
Loading...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EMITF vs. IQV commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMITF is a Hold and IQV is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (EMITF: $2.00 vs. IQV: $154.73)
Brand notoriety: EMITF: Not notable vs. IQV: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EMITF: 7% vs. IQV: 168%
Market capitalization -- EMITF: $11.9M vs. IQV: $45.3B
EMITF [@Medical Specialties] is valued at $11.9M. IQV’s [@Medical Specialties] market capitalization is $45.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EMITF’s FA Score shows that 1 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s).

  • EMITF’s FA Score: 1 green, 4 red.
  • IQV’s FA Score: 0 green, 5 red.
According to our system of comparison, EMITF is a better buy in the long-term than IQV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IQV’s TA Score shows that 4 TA indicator(s) are bullish.

  • IQV’s TA Score: 4 bullish, 4 bearish.

Price Growth

EMITF (@Medical Specialties) experienced а 0.00% price change this week, while IQV (@Medical Specialties) price change was -12.77% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.38%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

EMITF is expected to report earnings on Nov 29, 2024.

IQV is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Medical Specialties (-6.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IQV($45.3B) has a higher market cap than EMITF($11.9M). EMITF YTD gains are higher at: 33.333 vs. IQV (-21.261). IQV has higher annual earnings (EBITDA): 3.26B vs. EMITF (-294K). IQV has higher revenues than EMITF: IQV (15B) vs EMITF (0).
EMITFIQVEMITF / IQV
Capitalization11.9M45.3B0%
EBITDA-294K3.26B-0%
Gain YTD33.333-21.261-157%
P/E RatioN/A34.14-
Revenue015B-
Total CashN/A1.5B-
Total DebtN/A13.9B-
FUNDAMENTALS RATINGS
EMITF vs IQV: Fundamental Ratings
EMITF
IQV
OUTLOOK RATING
1..100
5059
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
5474
SMR RATING
1..100
8641
PRICE GROWTH RATING
1..100
3664
P/E GROWTH RATING
1..100
10083
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EMITF's Valuation (3) in the Real Estate Development industry is significantly better than the same rating for IQV (70) in the Servicestothe Health Industry industry. This means that EMITF’s stock grew significantly faster than IQV’s over the last 12 months.

EMITF's Profit vs Risk Rating (54) in the Real Estate Development industry is in the same range as IQV (74) in the Servicestothe Health Industry industry. This means that EMITF’s stock grew similarly to IQV’s over the last 12 months.

IQV's SMR Rating (41) in the Servicestothe Health Industry industry is somewhat better than the same rating for EMITF (86) in the Real Estate Development industry. This means that IQV’s stock grew somewhat faster than EMITF’s over the last 12 months.

EMITF's Price Growth Rating (36) in the Real Estate Development industry is in the same range as IQV (64) in the Servicestothe Health Industry industry. This means that EMITF’s stock grew similarly to IQV’s over the last 12 months.

IQV's P/E Growth Rating (83) in the Servicestothe Health Industry industry is in the same range as EMITF (100) in the Real Estate Development industry. This means that IQV’s stock grew similarly to EMITF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IQV
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
61%
MACD
ODDS (%)
Bearish Trend 3 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 14 days ago
62%
Declines
ODDS (%)
Bearish Trend 3 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
63%
View a ticker or compare two or three
Ad is loading...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VRIG25.03-0.04
-0.16%
Invesco Variable Rate Investment Grd ETF
IJUL27.71-1.12
-3.89%
Innovator Intl Dev Pwr Bffr ETF July
UMAY31.02-1.43
-4.42%
Innovator U.S. Equity Ultra BffrETF™-May
RNEW22.00-2.15
-8.89%
VanEck® Green Infrastructure ETF
DPST53.39-7.47
-12.27%
Direxion Daily Regional Bnks Bull 3X ETF

EMITF and

Correlation & Price change

A.I.dvisor tells us that EMITF and AVHHL have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EMITF and AVHHL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMITF
1D Price
Change %
EMITF100%
N/A
AVHHL - EMITF
26%
Poorly correlated
N/A
KLYG - EMITF
24%
Poorly correlated
-19.61%
ASAPF - EMITF
24%
Poorly correlated
-8.64%
IQV - EMITF
23%
Poorly correlated
-7.73%
PHG - EMITF
15%
Poorly correlated
-7.46%
More